Mutabilis
Romainville, FR· latest recorded location
MUTABILIS is named on 10 US grants and 14 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 10
- Published applications
- 14
- Inventors
- 30
- Granted in 2026 so far
- 0
- Most recent grant
- 9 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 2 | 4 |
| 2019 | 3 | 2 |
| 2020 | 3 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Technology areas
Share of 24 documents
- A61PTherapeutic uses of medicines24
- C07DHeterocyclic compounds20
- A61KMedicines and medical preparations19
- Y02ATechnologies for adaptation to climate change10
- C07KPeptides2
- C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen1
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
Recent patents
- Heterocyclic compounds and their use in preventing or treating bacterial infections9 Jan 2024US 11,865,118 B2
- Heterocyclic compounds and their use in preventing or treating bacterial infections20 Dec 2022US 11,530,227 B2
- Heterocyclic compounds and their use in preventing or treating bacterial infections24 Nov 2020US 10,842,779 B2
- Heterocyclic compounds and their use in preventing or treating bacterial infections28 Jul 2020US 10,722,520 B2
- Heterocyclic compounds and their use in preventing or treating bacterial infections25 Feb 2020US 10,570,131 B2
- Heterocyclic Compounds And Their Use in Preventing or Treating Bacterial Infections9 Sep 2021US 2021/0275542 A1
- Heterocyclic Compounds And Their Use in Preventing or Treating Bacterial Infections9 Sep 2021US 2021/0277019 A1
- Composition comprising antibiotic compound and an heterocyclic compound and their use in preventing or treating bacterial infections23 Jan 2020US 2020/0024278 A1
- Heterocyclic compounds and their use in preventing or treating bacterial infections25 Jul 2019US 2019/0224210 A1
- Heterocyclic compounds and their use in preventing or treating bacterial infections13 Jun 2019US 2019/0175561 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.